August Newsletter: Explore 5 Extraordinary New Ventures This Month

August Newsletter: Explore 5 Extraordinary New Ventures This Month image
Published September 9th, 2024 in Investment, Newsletter

August 2024

Featured Opportunity: Invest in the future of beekeeping: world-first honey testing tech

Discover a game-changing innovation in the beekeeping industry: The Experiment Company's Kanuka Honey potency test kit, a world-first that allows beekeepers to assess honey quality on-site. With commercial launch approaching, seize the chance to invest in this industry-shaking innovation.

Sign in to read the pitch >

____________________________________________________________________

New Zealand's start-up scene is exploding with unmissable opportunities. In just the last month, five groundbreaking ventures have surfaced on InvestaMatch - each primed to disrupt their markets.

From broad-spectrum antiviral therapeutics to cutting-edge road-monitoring systems and electric axles for freight trailers, these innovations tackle urgent global challenges.

So, astute investors - now is a fantastic time to take action.

“In today’s economic times, there’s no question that InvestaMatch’s offering could be more important than ever.” #nzentrepreneur’s recent profile on our unique approach to start-up funding is truly eye-opening. Click the link below to read the full story.

As always, thank you for being a part of the Investamatch community.

Ross Young, Founder.

____________________________________________________________________

Where to invest? How to choose a start-up business opportunity.

A step-by-step guide to making smart decisions with your investment dollars.

Read More >

____________________________________________________________________

#nzentrepreneur spotlights Investamatch

Why our unique approach meets the needs of today’s unique investment landscape.

Learn More >

____________________________________________________________________

Introducing: a revolutionary approach to antiviral therapeutics

Kimer Med is a NZ biotech company that is developing a family of new, broad-spectrum antivirals to treat a wide range of viral diseases. They are also pioneering a proprietary drug design, test and customisation platform. This is your chance to be part of something extraordinary.

Sign in to view >

Share on:

Be In The Know

Get the freshest opportunities and latest insights from our experts, straight to your inbox.